Not meaning to be a down ramper but really all of these things you state are really just guessing to be at stage 3 of an FDA approved trial and not sure or not have the data to show what we are actually going to use is an embarrassment a total embarrassment to the management and all involved. How could this happen and people somehow think all will be ok when we get some direction if we get direction from the FDA? They might want more evidence more data more information more of anything. This company is walking a very fine line, the last of our worries is the Bene agreement. Our worries start with money and end with money, those two recent appointments aren't here because they see a massive opportunity, they see a cluster F$&@K and a total sh!t show and are trying to save their investment. How PR got away with this is soul destroying and don't worry if he could sort a deal where he gets parachuted out for a princely sum and we RS get shafted don't worry he would jump at it. Sorry off my chest now good day.
PAR Price at posting:
42.0¢ Sentiment: Hold Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)